Introduction
Citrus peels are by-products of the citrus industry and are majorly considered as waste products in many countries. Large amount of peels are generated from the juice production process due to the fact that peels are about 65 of the total weight of the fruits 1 . While the developed countries have an efficient means of handling this waste, they are a major environmental menace in many developing countries. However, these peels have been shown to be excellent sources of bioactive compounds which possess medicinal potentials 2, 3 . Citrus peels are in use in Chinese medicine and African folklore in the management of degenerative conditions, though there is dearth of information on the scientific basis for the use of the peels. Much of the bioactivity of citrus peels have been linked to the phenolic content 4 , which are more concentrated in the peels that in the juices and seeds. However, there are a lot of other bioactive constituents, such as essential oils, which also contribute to their observed medicinal uses. Essential oils can be obtained in significant quantities from the peels of citrus fruits and they contain numerous compounds rich in been shown to possess anticholiensterase and antioxidative properties, there is dearth of information on the medicinal potentials of the peels, especially the essential oils, which are a major component of the peels and can be extracted in significant amount. This study, therefore investigated the anticholinesterase and antioxidative potentials of essential oils from Lemon peels.
Materials and Methods

Materials
Sample collection
Lemon Citrus limon peels were collected from the Akure South west, Nigeria main market. The peels were dried to a moisture content of 12 and ground to fine powder using Waring Commercial heavy Duty Blender Model 37BL18; 24ØCB6 . Authentication of the samples was carried out at the Department of Crop, Soil and Pest management CSP , Federal University of Technology, Akure, Nigeria. 2.1.2 Essential oil isolation 100 g of the ground orange peel powder was subjected to hydrodistillation for 3 h in an all glass Clevenger -type apparatus according to the method recommended by the European Pharmacopoeia 15 . The extracted oil sample was passed over anhydrous sodium sulphate and stored in sealed vials at 4 for further analysis 16 18 .
Chemicals and reagents
Chemicals and reagents used such as thiobarbituric acid TBA , 1,10-phenanthroline, deoxyribose, gallic acid, Folin-Ciocalteau s reagent were procured from Sigma-Aldrich, Inc., St Louis, MO , trichloroacetic acid TCA was sourced from Sigma-Aldrich, Chemie GmbH Steinheim, Germany , dinitrophenyl hydrazine DNPH from ACROS Organics New Jersey, USA , hydrogen peroxide, methanol, acetic acid, thiourea, Copper sulphate, sulfuric acid, sodium carbonate, aluminum chloride, potassium acetate, sodium dodecyl sulphate, iron II sulfate, potassium ferricyanide and ferric chloride were sourced from BDH Chemicals Ltd., Poole, England . Except stated otherwise, all other chemicals and reagents were of analytical grades and the water was glass distilled.
Methods
Determination of total phenol content
The total phenol content was determined according to the method of Singleton et al. 19 . Briefly, appropriate dilutions of the essential oil was oxidized with 2.5 mL 10 Folin-Ciocalteau s reagent v/v and neutralized by 2.0 mL of 7.5 sodium carbonate. The reaction mixture was incubated for 40 min at 45 and the absorbance was measured at 765 nm in the spectrophotometer. The total phenol content was subsequently calculated as gallic acid equivalent.
Determination of total flavonoid content
The total flavonoid content of the essential oil was determined using a slightly modified method reported by Meda et al. 20 . Briefly, 0.5 mL of appropriately diluted sample was mixed with 0.5 mL methanol, 50 μL 10 AlCl 3 , 50 μL 1 M potassium acetate and 1.4 mL water and allowed to incubate at room temperature for 30 min. The handling and the use of the animals were in accordance with NIH Guide for the care and use of laboratory animals. Male Wistar rats weighing 80 g -130 g used for this experiment were purchased from the breeding colony of the Department of Biochemistry, University of Ilorin, Nigeria. The rats were maintained at 25 on a 12 h light/dark cycle with free access to food and water. They were acclimatized under these conditions for two weeks prior to the commencement of the experiments.
Preparation of Brain Homogenates
The rats were decapitated under mild diethyl ether anaesthesia and the brain was rapidly isolated and placed on ice and weighed. This tissue was subsequently homogenized in cold saline 1/10 w/v with about 10-up-and -down strokes at approximately 1200 rev/min in a Teflon glass homogenizer. The homogenate was centrifuged for 10 min at 3000 xg to yield a pellet that was discarded, and a lowspeed supernatant S1 was kept for lipid peroxidation assay 22 .
2.2.5.3 Lipid Peroxidation and Thiobarbibutric Acid Reactions The lipid peroxidation assay was carried out using the modified method of Ohkawa et al. 23 . Briefly, 100 μl S1 fraction was mixed with a reaction mixture containing 30 μl of 0.1 M pH 7.4 Tris-HCl buffer, essential oil 0 -100 μl and 30 μl of 250 μM freshly prepared FeSO 4 the procedure was also carried out using 15 mM quinolinic acid . The volume was made up to 300 μl by water before incubation at 37 for 1 h. The colour reaction was developed by adding 300 μl 8.1 SDS Sodium doudecyl sulphate to the reaction mixture containing S1, which was subsequently followed by the addition of 600 μl of acetic acid/HCl pH 3.4 mixture and 600 μl 0.8 TBA Thiobarbituric acid . This mixture was incubated at 100 for 1 h. TBARS Thiobarbituric acid reactive species produced were measured at 532 nm and the absorbance was compared with that of standard curve using MDA Malondialdehyde . 2.2.6 Determination of DPPH* scavenging ability The free radical scavenging ability of the oil extract against DPPH free radical was evaluated as described by Gyamfi et al. 24 . Briefly, an appropriate dilution of the extract 1 mL was mixed with 1 mL 0.4 mM DPPH radicals in methanolic solution. The mixture was left in the dark for 30 min, and the absorbance was taken at 516 nm. The control was carried out by using 2 mL DPPH solution without the test samples. The DPPH free radical scavenging ability was subsequently as percentage of the control. 2.2.7 Determination of ABTS* scavenging ability The total antioxidant capacity was determined based on 2,2-azinobis 3-ethylbenzothiazoline-6-sulfonate radical ABTS scavenging ability of the extract according to the method described by Re et al. 25 . ABTS was generated by reacting ABTS aqueous solution 7 mM with K 2 S 2 O 8 2.45 mM, final concentration in the dark for 16 h and adjusting the absorbance at 734 nm to 0.700 with ethanol. 0.2 mL of appropriate dilution of the extract was added to 2.0 mL ABTS solution and the absorbance was measured at 734 nm after 15 min. The trolox equivalent antioxidant capacity TEAC was subsequently calculated using trolox as the standard.
Determination of Reducing Power
The reducing property of the extract was determined by assessing the ability of the extract to reduce FeCl 3 solution as described by Oyaizu 26 . A 2.5 mL aliquot was mixed with 2.5 mL of 200 mM sodium phosphate buffer pH 6.6 and 2.5 mL of 1 potassium ferricyanide. The mixture was incubated at 50 for 20 min and then 2.5 mL of 10 trichloroacetic acid was added. This mixture was centrifuged at 801 g for 10 min. 5 mL of the supernatant was mixed with an equal volume of water and 1 mL of 0.1 ferric chloride. The absorbance was measured at 700 nm and ferric reducing power was subsequently calculated using ascorbic acid equivalent. 2.2.9 Nitric oxide scavenging activity Nitric oxide scavenging assay was performed using griess reagent method by method reported by Susanta et al. 27 .
Briefly, 0. , and the volume was made up to 800 μL with distilled water. The reaction mixture was incubated at 37 for 30 min, and the reaction was then stopped by the addition of 0.5 mL of 2.8 trichloroacetic acid TCA , this was followed by the addition of 0.4 mL of 0.6 thiobarbituric acid TBA solution. The tubes were subsequently incubated in boiling water for 20 min. The absorbance was measured at 532 nm in spectrophotometer. The percentage ˙OH radical scavenging ability was subsequently calculated.
Data Analysis
The results of the three replicates were pooled and expressed as mean standard deviation S.D. . Student s t-test and the least significance difference LSD were carried out 31 . Significance was accepted at p ≤ 0.05. EC 50 was determined using linear regression analysis.
Results and Discussion
Phenolic Distribution and chemical constituents
The results of the total phenol and flavonoid distribution in the lemon peel essential oil are presented in Table 1 . The total phenolic content reported as gallic acid equivalent was 7.42 mg/100 g, while the total flavonoid content reported as quercetin equivalent was 3.56 mg/100 g. The GC analysis as presented in Table 2 
Anticholinesterase activity
The effects of the essential oil on acetylcholinesterase and butyrylcholinesterase activities are presented in Fig. 1 and 2. The EC 50 values for the dose-dependent inhibition of AChE and BChE activities by the essential oil were 164.35 μL/L and 169.32 μL/L respectively. The EC 50 values for prostigmine inhibition of AChE and BChE activities were 45.82 μg/L and 44.38 μg/L respectively. The dose-dependent inhibition of acetylcholinesterase AChE and butyrylcholinesterase BChE activity by the lemon peel essential oil is of immense importance in the management of neurodegenerative conditions as this increases communication between nerve cells 32 . More so, the butyrylcholinesterase BChE inhibition by the essential oils is also beneficial as BChE increases the neurotoxicity of certain plaques thereby making the brain more susceptible to Alzheimer s disease 33, 34 . The anticholinesterase activity of the essential oil could be linked to the phenolic content, as some phenolic rich plant extracts have been shown to inhibit cholinesterases 35 . The anticholinesterase property of the essential oil was lower than that of prostigmine as shown in Fig. 1 and 2, however the side effects experienced with synthetic cholinesterase inhibitors are not expected to be experi- Table 1 The total phenolic content reported as gallic acid equivalent, total flavonoid content reported as quercetin equivalent, trolox equivalent antioxidant capacity and ferric reducing antioxidant property reported as ascorbic acid equivalent. 8, 9 . The anticholinesterase activity of the essential oil could also be linked to the presence of some constituents identified by GC analysis such as borneol, b-pinene and 1,8-cineole, which have been reported to possess anticholinesterase properties 32, 36 .
The synergistic action of the volatile compounds identified in the oils, majorly classified as monoterpenoids and phenylpropanoids could contribute to their cholinesterase inhibitory ability 37, 38 . Furthermore, Mukherjee et al. 13 att r i b u t e d t h e a n t i -c h o l i n e s t e r a s e a c t i v i t y o f phenylpropanoids to hydrophobic interactions between their hydrocarbon skeleton and the hydrophobic active site of AChE.
Lipid preoxidation Inhibition
The incubation of rat s brain homogenates in presence of Fe 2 and quinolinic acid caused a significant increase p 0.05 in the malondialdehyde MDA content as shown in induced MDA production in a dose-dependent manner with EC 50 values of 90.68 μL/L which could be attributed to the ability of the oil to chelate Fe 2 or scavenge OH* 39 . Reactive oxygen species-induced malondialdehyde MDA production in the brain has been linked to the development of Alzheimer s disease since there is a huge amount of brain phospholipids which are easily attacked by free radicals 11, 40, 41 . The incidence of neurodegenerative conditions have been linked to increased levels of iron in the brain through increased iron transportation across the blood-brain barrier 42 . Iron then causes harmful effects in the brain by decomposing hydrogen peroxide to produce hydroxyl radicals OH* . Therefore, the OH* scavenging ability of the essential oil could be a possible mechanism by which they protect the brain from lipid peroxidation 39, 43 .
Similarly, the incubation of rat s brain homogenates in presence of quinolinic acid caused a significant increase in the MDA content due to increased lipid peroxidation brought about by the ability of quinolinic acid to form complexes which induce excess free radical formation 44 .
Quinolinic acid has been implicated in many neurodegenerative conditions including Alzheimer s disease and Parkinson s disease 45 47 . The essential oil inhibited quinolinic acid-induced MDA production in a dose-dependent manner with EC 50 value of 89.95 μL/L. The inhibition of quinolinic acid induced-lipid peroxidation by the essential oils as well as the NO* scavenging ability could be beneficial in the management of neurodegenerative conditions because quinolinic acid has been linked to AD development through the production of NO* in the brain 48 . Two of the lemon essential oil compounds, limonene and linalool have been shown to inhibit MDA production when fed to female rats given an ovedose of 7,12-dimethylbenz a anthracene DMBA 49 .
Antioxidant activity
Antioxidants have been proposed to be beneficial in the management of neurodegenerative conditions as the role of free radicals in such conditions have been well established since brain cells consume a high amount of oxygen 14 . The radical scavenging ability of the essential oil used in this study is exhibited by their DPPH, ABTS, OH and NO radicals scavenging activities. The ABTS* scavenging ability presented as trolox equivalent antioxidant capacity of the essential oil was 3.64 mmol./TEAC g and the ferric reducing ability presented as ascorbic acid equivalent was 27.09 mg/100g. Furthermore, the lemon peel essential oil scavenged DPPH*, OH* and NO* in dose-dependent manner and the EC 50 values were 205.93 μL/L DPPH* , 191.62 μL/L OH* and 340.24 μL/L NO* Figs. 5A , 5B, 5C . The radical scavenging abilities of the essential oil could be linked to the presence of phenolic monoterpenes 50 . Although, Aazza et al. 51 showed that some of the essential oil components of lemon peels as revealed by this study such as α-pinene, b-pinene, limonene, linalool, 1,8-cineole, linalyl acetate and borneol had less than 50 DPPH* scavenging ability, the observed radical scavenging ability of the essential oils used in this study could be a result of synergistic effect of the volatile constituents Figure 5D showed that the essential oil had a dose-dependent Fe 2 chelating ability with EC 50 value of 133.5 μL/ L. Iron plays an important role in the generation of hydroxyl radicals 52 and also in the development of neurodegenerative conditions as it accumulates in the brain of patients with Alzheimer s disease 53 . The ferric reducing antioxidant property and Fe 2 chelating ability of the citrus peel essential oil could therefore be beneficial in the management/ prevention of neurodegenerative conditions. The ferric reducing ability of the essential oil could be attributed to constituents such as α-pinene, limonene, linalool, 1,8-cineole and linalyl acetate, which have been shown to have reductive potential 51 . The Fe 2 chelating ability of the essential oil could be attributed to the presence of functional groups such as -OH in linalool and borneol, -O -in 1,8-cineole and -C O -in linalyl acetate in a favourable structure-function configuration 54 56 . The EC 50 values revealed that the essential oil had significantly higher Fe 2 chelating ability than OH* scavenging ability. The higher Fe 2 chelating ability of the essential oil could be of therapeutic importance in the protective ability of the essential oil against oxidative stress, due to the high reactivity of OH* 43 .
Conclusion
The inhibition of cholinesterases and Fe 2 and quinolinic acid-induced MDA production as well as radicals DPPH*, ABTS*, OH* and NO* scavenging abilities are possible mechanisms by which lemon peel essential oil could be used in the management and/or prevent neurodegenerative conditions. However, further in vivo experiments and clinical trials are recommended. 
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